Is Target Stock a Hidden Gem for Patient Value Investors?
Target (NYSE: TGT) hasn’t had the best run lately. In fact, shares have slid 29.9% so far this year, a sharp contrast to the broader market, with the S&P 500 flat on the year. It’s a tough pill to swallow, especially when you consider Target was already on the back foot coming into 2025.
But here’s the twist,
» Read more about: Is Target Stock a Hidden Gem for Patient Value Investors? »